Genialis
Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform.
About Genialis
Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform. It engages in unraveling complex biology to find new ways to address disease. Its platform defines, models, and validates actionable biomarkers and optimally positions novel drugs to accelerate translational research and clinical development. Genialis was established in 2015 in Boston, Massachusetts by Rafael Rosengarten.
Company Facts
- Headquarters
- Boston
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $15,491,319
- Last Funding Type
- series_a
- Last Funding Date
- 2023-03-29
- Website
- genialis.com
Industries & Categories
Bioinformatics, Biotechnology, Health Care, Medical, Precision Medicine
Social Links
Canonical: https://fsome.com/organization/genialis-75923 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.